ANTI-FUNGAL EFFECT OF USNIC ACID COMBINED GRAPHENE NANO-FORMULATION BY USING IN-VITRO METHOD

Main Article Content

Nimesh Kumar Dubey
Ritesh Jain
Neeraj Sharma
Dharmendra Singh Rajput

Keywords

Anti-fungal, Graphene, Nano-precipitation, Nano-ointment, Usnic acid

Abstract

Objective: The primary objective of this work is to examine the antifungal properties of usnic acid, a secondary metabolite found in lichens, when combined with graphene as a carrier.


Methods: The formulation of the nano-ointment combining graphene and usnic acid was achieved using the nano-precipitation technique using sonication. The in-vitro antifungal activity was conducted in order to validate the antifungal efficacy of the nano-ointment formulation.


Result: In the context of treating fungal infections, it is more appropriate to utilize topical medication administration. Therefore, the ointment was formulated by including the nano-combination using geometric mixing. A four-day in-vitro investigation was conducted to investigate the anti-fungal properties. The study revealed that usnic acid in its regular form, as well as graphene in its nano form, had anti-fungal properties, as evidenced by the observed zone of inhibition of 3mm and 5mm, respectively.


Conclusion: In conclusion, the findings of this study demonstrate that the nano-ointment formulation of usnic acid with graphene exhibited superior anti-fungal action compared to the conventional formulation.

Abstract 60 | pdf Downloads 49

References

1. Bhattacharya Sankha, Prajapati G Bhupendra. Formulation and optimization of celecoxib nanoemulgel. Asian J Pharm Clin Res 2018; 11: 353-65.
2. Gupta SK, “Introduction to Pharmaceutics II” fourth edition; CBS Publishers and Distributors Pvt. Ltd. 2011; p: 184-215.
3. Jain S, Padsalg BD, Patel AK, Moale V. Formulation development and evaluation of fluconazole gel in various polymer base. Asian J Pharm 2007; 1: 63-8.
4. Krzeminska Guzow et al, Antibacterial activity of lichen secondary metabolic usnic acid is primary caused by inhibition of RNA and DNA. FEMS Microbiology letters 2014; 353: 57-62.
5. Mayer M, et al. Usnic acid a non-genotoxic compound with anti-cancer properties. Anti-cancer Drugs 2005; 16: 805-9.
6. Nayak SH, Nakhat PD, Yeole PG, Development and evaluation of cosmeceutical hair styling gels of ketoconazole. Indian J Pharm Sci 2005; 52: 231-33.
7. Nihal Badduri, Gupta Vishal N, Gowda DV, M Manohar. Formulation and development of anti acne formulation of Spirulina Extract. Int J App Pharm; 10: 229-33.
8. Pandian Sundara M, Karthikeyini Chitra S, Nagarjan M. Fabrication, characterization and pharmacological activity of usnic acid loaded nanoparticles. International J Pharm Sci Res 2017; 8: 4758-66.
9. Pandey et al, Synthesis and characterization of graphene-usnic acid conjugate microspheres and its antibacterial activity against staphylococcus aureus International J Pharm Sci Res 2019; 10: 939-46.
10. Pershing LK, Corlett LJ, Jorgensen C. In vivo pharmacokinet Bics and pharmacodynamics of topical ketoconazole and miconazole in human stratum corneum Antimicrob. Agents Chemother 1994; 38: 90–5.
11. Queiroz MBR, Marcelino NB, Ribeiro MV, Espindola LS, Cunha F, Silva MV. Development of gel with Matricaria recutita L. extract for topical application and evaluation of physical-chemical stability and toxicity. Lat Am J Pharm 2009; 28: 574-9.
12. S Princely, MD Dhanaraju. Design, formulation and characterization of liposomal encapsulated gel for transdermal delivery of fluconazole. Asian J Pharm Cli Res 2018; 11: 417-24.
13. Vyas and khar “Targeted and Controlled Drug Delivery” first edition; CBS Publishers and Distributors Pvt. Ltd. 2013; p: 331-86.